Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 2
2006 2
2007 2
2008 2
2009 3
2010 5
2011 4
2012 5
2013 6
2014 4
2015 2
2016 2
2018 6
2019 5
2020 3
2021 4
2022 2
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Imaging in ocular toxoplasmosis.
Lavinsky D, Romano A, Muccioli C, Belfort R Jr. Lavinsky D, et al. Int Ophthalmol Clin. 2012 Fall;52(4):131-43. doi: 10.1097/IIO.0b013e318265fd78. Int Ophthalmol Clin. 2012. PMID: 22954935 Review. No abstract available.
Novel perspectives on swept-source optical coherence tomography.
Lavinsky F, Lavinsky D. Lavinsky F, et al. Among authors: lavinsky d. Int J Retina Vitreous. 2016 Nov 1;2:25. doi: 10.1186/s40942-016-0050-y. eCollection 2016. Int J Retina Vitreous. 2016. PMID: 27847643 Free PMC article. Review.
Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis.
Paganelli F, Cardillo JA, Dare AR, Melo LA Jr, Lucena DR, Silva AA Jr, Oliveira AG, Pizzolitto AC, Lavinsky D, Skaf M, Souza-Filho AA, Höfling-Lima AL, Nguyen QD, Kuppermann BD, Herrero-Vanrell R, Belfort R Jr; Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group. Paganelli F, et al. Among authors: lavinsky d. Expert Opin Drug Deliv. 2010 Aug;7(8):955-65. doi: 10.1517/17425247.2010.498817. Expert Opin Drug Deliv. 2010. PMID: 20645672 Review.
Plasma levels of miR-29b and miR-200b in type 2 diabetic retinopathy.
Dantas da Costa E Silva ME, Polina ER, Crispim D, Sbruzzi RC, Lavinsky D, Mallmann F, Martinelli NC, Canani LH, Dos Santos KG. Dantas da Costa E Silva ME, et al. Among authors: lavinsky d. J Cell Mol Med. 2019 Feb;23(2):1280-1287. doi: 10.1111/jcmm.14030. Epub 2018 Nov 23. J Cell Mol Med. 2019. PMID: 30467971 Free PMC article.
62 results